CAEBV

Clinical trials for CAEBV explained in plain language.

Never miss a new study

Get alerted when new CAEBV trials appear

Sign up with your email to follow new studies for CAEBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo takes on stubborn Epstein-Barr virus

Disease control Recruiting now

This study tests whether combining two drugs, golidocitinib and selinexor, can control chronic active Epstein-Barr virus disease (CAEBVD). Researchers will enroll 28 adults with CAEBVD and track how well the treatment reduces symptoms and lowers virus levels in the blood. It is a…

Matched conditions: CAEBV

Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

CAEBV

Get alerted when new CAEBV trials appear

New drug duo takes on stubborn Epstein-Barr virus